太安堂(002433.SZ)擬出售康愛多不超60%股權
格隆匯 7 月 10日丨太安堂(002433.SZ)公佈,公司以“建成世界一流的以太安堂絕技和高科技為特色的大型藥企”為目標,結合公司在中成藥領域長期積累的技術和品牌優勢,公司管理層近年來在戰略規劃上將資源重點集聚在中成藥藥品的研發、生產與銷售業務,繼續提升在生殖健康類藥、中藥皮膚類藥、心腦血管類藥等幾大類品種的優勢,實現公司經營規模和經營質量的健康發展。
為進一步聚焦主營業務,籌集資金償還債務,優化公司資產負債結構,改善公司資產質量,增強公司持續經營能力,公司擬向公司控股股東太安堂集團有限公司(“太安堂集團”)及相關產業投資機構出售持有的控股子公司廣東康愛多數字健康科技有限公司(“康愛多”)的股權,出售比例不超過60%,目前公司已與太安堂集團及相關產業投資機構簽訂了《關於廣東康愛多數字健康科技有限公司的股權轉讓意向書》。截至公告日,公司持有康愛多78.51%的股權,此次股權出售後,康愛多將成為公司參股公司。
經初步研究和測算,根據《上市公司重大資產重組管理辦法》的相關規定,此次交易構成重大資產重組;同時因公司控股股東太安堂集團計劃受讓部分公司所持有康愛多的股權,根據《深圳證券交易所股票上市規則》的相關規定,此次交易構成關聯交易。
此次交易完成後,公司將剝離互聯網醫藥電商業務資產,通過出售資產回籠資金用於償還相關債務。此次交易有利於集中資源強化公司核心產品競爭力,優化公司的資產結構,同時有利於進一步壓縮公司有息債務規模,降低財務費用,提升公司償債能力,改善公司資產質量與財務狀況,最終改善上市公司的持續經營能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.